Becton Dickinson
Trade Becton Dickinson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BDX
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional.
BDX Key Statistics
Stock Snapshot
The current Becton Dickinson(BDX) stock price is $206.18, with a market capitalization of 58.73B. The stock trades at a price-to-earnings (P/E) ratio of 34.97 and offers a dividend yield of 2.1%.
On 2026-01-21, Becton Dickinson(BDX) stock moved within a range of $204.13 to $207.54. With shares now at $206.18, the stock is trading +1.0% above its intraday low and -0.7% below the session's peak.
Trading volume for Becton Dickinson(BDX) stock has reached 1.74M, versus its average volume of 1.62M.
The stock's 52-week range extends from a low of $162.29 to a high of $251.99.
The stock's 52-week range extends from a low of $162.29 to a high of $251.99.
BDX News
Becton Dickinson (NYSE:BDX) received FDA clearance for its EnCor EnCompass Breast Biopsy and Tissue Removal System. The clearance adds a new multi modality bre...
Becton Dickinson (BDX) and Ypsomed are strengthening their collaboration with the development of a 5.5 mL version of the BD Neopak XtraFlow Glass Prefillable Sy...
Insiders have been trading these 5 stocks: ((MVST)), ((DVLT)), ((RH)), ((BDX)) and ((VSTM)). Here is a breakdown of their recent trades and their value. Claim 7...
Analyst ratings
69%
of 16 ratingsMore BDX News
New insider activity at Becton Dickinson ( (BDX) ) has taken place on January 16, 2026. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful...
In recent trading, shares of Becton, Dickinson & Co (Symbol: BDX) have crossed above the average analyst 12-month target price of $203.90, changing hands for $2...
Advertisement Why BD’s syringe expansion matters for shareholders Becton Dickinson (BDX) is committing US$110 million to expand Neopak Glass Prefillable Syrin...